Expression and activation of ErbB2, ErbB3, and their ligand, neuregulin during sciatic nerve regeneration

被引：0
作者：
Cheon, K
Kim, M
Marchionni, MA
Kwon, YK
机构：
[1] Kyung Hee Univ, Dept Biol, Seoul 130701, South Korea
[2] Cambridge NeuroSci Inc, Cambridge, MA USA
来源：
JOURNAL OF NEUROCHEMISTRY | 1998年 / 70卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
[31]   Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer [J].
Loree, Jonathan M. ;
Bailey, Ann M. ;
Johnson, Amber M. ;
Yu, Yao ;
Wu, Wenhui ;
Bristow, Christopher A. ;
Davis, Jennifer S. ;
Shaw, Kenna R. ;
Broaddus, Russell ;
Banks, Kimberly C. ;
Lanman, Richard B. ;
Meric-Bernstam, Funda ;
Overman, Michael J. ;
Kopetz, Scott ;
Raghav, Kanwal .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (12) :1409-1417
[32]   Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 [J].
José Baselga ;
Sandra M. Swain .
Nature Reviews Cancer, 2009, 9 :463-475
[33]   Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3 [J].
Sak, Malgorzata Magdalena ;
Szymanska, Monika ;
Bertelsen, Vibeke ;
Hasmann, Max ;
Madshus, Inger Helene ;
Stang, Espen .
CARCINOGENESIS, 2013, 34 (09) :2031-2038
[34]   Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 [J].
Baselga, Jose ;
Swain, Sandra M. .
NATURE REVIEWS CANCER, 2009, 9 (07) :463-475
[35]   Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2 [J].
Maurer, CA ;
Friess, H ;
Kretschmann, B ;
Zimmermann, A ;
Stauffer, A ;
Baer, HU ;
Korc, M ;
Büchler, MW .
HUMAN PATHOLOGY, 1998, 29 (08) :771-777
[36]   Expression of heregulin-A, ERBB2 and ERBB3 and the influences on epithelial cell proliferation in the stomach [J].
Noguchi, H ;
Sakamoto, C ;
Wada, K ;
Akamatsu, T .
GASTROENTEROLOGY, 1999, 116 (04) :A569-A569
[37]   ErbB2 without ErbB3 expression in metaplastic columnar epithelium of Barrett's esophagus [J].
Nishigaki, H ;
Wada, K ;
Tatsuguchi, A ;
Sueoka, N ;
Futagami, S ;
Gudis, K ;
Miyake, K ;
Tsukui, T ;
Sakamoto, C .
DIGESTION, 2004, 70 (02) :95-102
[38]   Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3 [J].
McDonagh, Charlotte F. ;
Huhalov, Alexandra ;
Harms, Brian D. ;
Adams, Sharlene ;
Paragas, Violette ;
Oyama, Shinji ;
Zhang, Bo ;
Luus, Lia ;
Overland, Ryan ;
Stephanie Nguyen ;
Gu, Jinming ;
Kohli, Neeraj ;
Wallace, Matt ;
Feldhaus, Michael J. ;
Kudla, Arthur J. ;
Schoeberl, Birgit ;
Nielsen, Ulrik B. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) :582-593
[39]   ErbB2, ErbB3 and ErbB4 expression in urothelial tumors of the upper urinary tract and their prognostic significance [J].
Galanakis, I. ;
Spyropoulos, E. ;
Gkialas, I. ;
Nomikos, A. ;
Souka, E. ;
Mitropoulos, D. .
JOURNAL OF BUON, 2013, 18 (03) :653-659
[40]   Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2–ErbB3 complex in their active conformations [J].
Juan Felipe Franco-Gonzalez ;
Javier Ramos ;
Victor L. Cruz ;
Javier Martínez-Salazar .
Journal of Molecular Modeling, 2013, 19 :931-941
12345